Patrick Flynn

Director/Board Member at NeuroRx, Inc.

Health Technology

Profile

Patrick Flynn has worked as a Director at Common Sensing, Inc. since 2013 and is currently employed there.
He is also currently a Director at NeuroRx, Inc.

Patrick Flynn active positions

Companies	Position	Start
NeuroRx, Inc. NeuroRx, Inc. BiotechnologyHealth Technology NeuroRx, Inc. operates as a clinical stage, small molecule pharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders. The company was founded by Jonathan C. Javitt and Daniel C. Javitt in 2015 and is headquartered in Wilmington, DE.	Director/Board Member	-
Common Sensing, Inc. Common Sensing, Inc. Medical SpecialtiesHealth Technology Common Sensing, Inc. engages in the provision of medical devices services. Its products includes the Gocap System, which utilizes a smart cap that automatically sends drug-delivery data from disposable pen-injectors to a mobile app. The company was founded by Richard Whalley and James White in September 2012 and is headquartered in Cambridge, MA.	Director/Board Member	01/06/2013

All active positions of Patrick Flynn

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Patrick Flynn's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
NeuroRx, Inc. NeuroRx, Inc. BiotechnologyHealth Technology NeuroRx, Inc. operates as a clinical stage, small molecule pharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders. The company was founded by Jonathan C. Javitt and Daniel C. Javitt in 2015 and is headquartered in Wilmington, DE.	Health Technology
Common Sensing, Inc. Common Sensing, Inc. Medical SpecialtiesHealth Technology Common Sensing, Inc. engages in the provision of medical devices services. Its products includes the Gocap System, which utilizes a smart cap that automatically sends drug-delivery data from disposable pen-injectors to a mobile app. The company was founded by Richard Whalley and James White in September 2012 and is headquartered in Cambridge, MA.	Health Technology